Business Wire

UEC Shows Latest Russian Civil Aero Engines at Paris Air Show

Jaa

Russian United Engine Corporation (UEC), specialising in development, serial production, service and support of engines for civil and military aviation, space programmes and navy, as well oil and gas industry and power generation, presents the modern Russian commercial aero engines at Paris Air Show 2017 and holds talks with the foreign partners on the promising projects.

In Le Bourget, UEC demonstrates the brand-new PD-14 engine, developed for MC-21-300 narrow-body airliner, the Russian-French engine SaM146 (installed on Sukhoi Superjet 100 regional passenger jets). Also the Corporation presents its capacity as the Tier 2-4 supplier.

Within the framework of the business programme UEC discusses the cooperation with the leaders of the world's aerospace industry, for example, with Safran Group. UEC also conducts a presentation of the PD-14 engine for the potential customers, during which they are able to acquaint themselves with its competitive advantages.

“We consider our participation in Paris Air Show 2017 an efficient marketing instrument for promoting our competencies on the civil aviation global market. —Alexander Artyukhov, UEC Director General says. — At the same time we are going to base our further work not only on exporting the end products, but firstly, on taking part in the export-oriented projects, or in other words, cooperation with the foreign companies in the field of developing engines and its components “.

PD-14 is a new generation turbofan engine created with the extensive use of the most up-to-date technologies and materials, including the composites. This is the first engine for commercial airliners successfully designed and developed in modern Russia. Presently UEC is conducting the integrated trials of the PD-14 engine in accordance with the certification basis. The tests are being performed strictly in line with the schedule. In 2015 – 2017, the first and the second stages of the PD-14 flight test on a flying testbed and a number of other special tests had been successfully performed at all operational speeds, altitudes and thrust ranges. The workability of the engine in the real operation conditions had been confirmed. The flight trials will be continued this year.

PD-14 is designed along the time-tested turbofan engine scheme: compact twin-spool structure, direct drive fan, optimised bypass ratio, FADEC control system. This provides a high reliability and maintainability and reduction of expenses. The modular design along with the digital control system, the built-in diagnostic system and the effective after-sales support system ensure the successful implementation of the operation on the technical condition.

UEC is promoting PD-14 abroad as a power plant of MC-21-300 airliner. Also, the corporation is ready to offer its foreign partners the cooperation in the field of developing on the base of PD-14 engines for airliners and transport airplanes of various classes.

Applying the technologies mastered in the framework of PD-14 project UEC is currently developing the high-thrust PD-35 civil engine, intended for powering the future wide body long-haul airplanes.

SaM146 engine, being another future of UEC stand at Le Bourget, is successfully being operated all around the world by well-known airlines such as Russian Aeroflot, Mexican Interjet and Irish CityJet – altogether 15 operators. Some of them are conducting very intensive operations in harsh environments. Since starting revenue service in 2011, the SaM146 engine has demonstrated exceptional performance in service, with an engine dispatch reliability of 99,9%.

The deliveries of SaM146 and all the after-sales services are performed by PowerJet, a joint venture formed on the principles of equal representation by Safran Aircraft Engines and Russian UEC-Saturn (part of UEC).

Contact information

United Engine Corporation
Alexander Artyukhov
press@uecrus.com
Tel. +7 (499) 558-38-83

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Yokogawa Develops N-IO Standard Field Enclosure and Control System Virtualization Platform18.12.2017 05:00Tiedote

Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed an N-IO standard field enclosure and a control system virtualization platform. The enclosure is a weatherproof remote IO cabinet that stores IO devices used by the CENTUM(R) VP integrated production control system and the ProSafe(R)-RS safety instrumented system, and the virtualization platform enables the control of multiple virtual devices on a single server. By reducing the amount of time and effort to engineer a new system, these solutions help to both speed up project execution and reduce total cost of ownership (TCO). The N-IO standard field enclosure is scheduled to be released in February 2018, and the virtualization platform will be released in May 2018. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171217005010/en/ N-I

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13Tiedote

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21Tiedote

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38Tiedote

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00Tiedote

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme